therapeutic areas -
Ferring develops important new medicines for patients with urological diseases.
We are dedicated to providing treatments that improve the quality of life for:
- adults living with nocturia
- children living with bedwetting
- men affected by prostate cancer
- men affected by the symptoms of low levels of testosterone
Ferring has a long history in Urology since the launch of the anti-diuretic peptide in 1972. We conduct clinical trials globally to meet the requirements for approval and marketing. The clinical research is recognised for high quality and scientific focus, and has resulted in new successful urology products which improve the quality of life and address life threatening diseases of millions of patients all over the world.
The message has been sent
Your friend has been sent the following email: